Year Ended December 31, 2021 2020 Supplemental disclosure of cash flow information Income taxes paid $ 400 $ 130 Interest paid 5,628 5,912 Interest received — 68 Noncash transactions: Purchases of property and equipment, including internal-use software 118 323 Common stock issued in Exchange for 2016 Notes 10,000 — (1) Cash and cash equivalents included restricted cash of $2,318, $1,375, and $1,136 at December 31, 2021, 2020, and 2019, respectively. At December 31, 2021, restricted cash of $1,180 is included in prepaid expenses and other current assets and $1,138 is included in other assets. At December 31, 2020, restricted cash of $237 is included in prepaid expenses and other current assets and $1,138 is included in other assets. At December 31, 2019, restricted cash of $1,136 is included in other assets. Restricted cash consists of funds that are contractually restricted as to usage or withdrawal related to the Company's security deposits in the form of standby letters of credit for leased facilities and funds held in an escrow account related to the sale of the Connected Care Business (see Note 4). No amounts have been drawn upon the letters of credit as of December 31, 2021. (2) The statements for the year ended December 31, 2020 includes the Connected Care Business (see Note 4). The accompanying notes are an integral part of these Consolidated Financial Statements. NantHealth, Inc. Consolidated Statements of Cash Flows (Dollars in thousands) - 101 -
RkJQdWJsaXNoZXIy NTIzOTM0